London, UK – Wednesday 15 September 2021 - The Global Generics and Biosimilars Awards finalists have been announced prior to the Awards ceremony taking place in Milan, Italy in November 2021.
The Awards recognize achievements across the global off-patent industry, including breakthroughs in small-molecule generics, biosimilars and value-added medicines; as well as celebrating the industry’s biggest deals, regulatory milestones and company leaders. There are 14 categories, including global and regional Company of the Year, Biosimilar Initiative of the Year, Industry Partner of the Year, Regulatory Achievement of the Year and Value Added Medicines Initiative of the Year.
View the full list of Global Generics and Biosimilars Awards 2021 finalists and categories here.
David Wallace, Executive Editor, Generics Bulletin, said “We’re thrilled to announce the Global Generics and Biosimilars Awards finalists for 2021. The Awards acknowledge the tremendous achievements made by the off-patent industry in delivering high-quality medicines to those around the globe who need them most.”
Entries were carefully reviewed by the judging panel - a series of experts from the generics, biosimilars and value-added medicines industries, each of whom has volunteered their time and experience in supporting and ensuring the integrity of the Awards.
“With the pandemic continuing to pose challenges to the industry and healthcare sector, there has never been a more appropriate time to recognize the ongoing efforts made by off-patent pharmaceutical providers,” said David Wallace. “We’ve been impressed by the high level of the entries. It’s clear to see that individuals and companies have thrived by quickly adapting and working to overcome these challenges. A huge congratulations to all those who’ve been shortlisted.”
About Informa Pharma Intelligence
Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, medtech and biotech organizations, and healthcare service providers, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline to pharmaceutical and biomedical decision makers around the world.
At Pharma Intelligence, global teams of subject area experts follow and analyze key diseases, clinical trials, drug approvals and R&D activities as part of the breadth and depth of data available to customers.
For more information visit pharmaintelligence.informa.com.
About Global Generics and Biosimilars Awards
The Global Generics & Biosimilars Awards is the one night of the year when the off-patent pharmaceutical industry’s greatest achievements are put in the spotlight.
Taking place November 10, 2021 at the Stella Polare, Fiera Milano, Milan, Italy, the Global Generics & Biosimilars Awards 2021 recognizes companies across the off-patent industry, including small-molecule generics, biosimilars and value-added medicines, by celebrating their successes over the past year.